Cargando…
Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
INTRODUCTION: Cardiovascular diseases (CVD) are a leading cause of death worldwide, and several modifiable and unmodifiable risk factors contribute to this burden of disability and mortality. Thus, effective cardiovascular prevention relies on appropriate strategies to control risk factors within th...
Autores principales: | Del Pinto, Rita, Giua, Corrado, Keber, Enrico, Grippa, Eleonora, Tilotta, Marco, Ferri, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090023/ https://www.ncbi.nlm.nih.gov/pubmed/36906668 http://dx.doi.org/10.1007/s40292-023-00568-3 |
Ejemplares similares
-
Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
por: Del Pinto, Rita, et al.
Publicado: (2023) -
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
por: Dan, Gheorghe-Andrei
Publicado: (2021) -
Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
por: Maher, Vincent, et al.
Publicado: (2023) -
Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists
por: Giua, Corrado, et al.
Publicado: (2021) -
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)